Reviewing performance

In this clinical audit, you will identify patients with COPD who have a history of moderate to severe exacerbations in the past 12 months and an increased risk of cardiovascular events. You will consider how your patient’s self-management behaviours, inhaled COPD medications and prescribed non-pharmacological treatments could be further optimised, in line with evidence-based guidelines, to improve symptom control and reduce the risk of further exacerbations.

In this clinical audit, you will conduct Heart Health Checks for your patients, providing comprehensive cardiovascular risk assessments and developing ongoing management plans involving pharmacological and lifestyle strategies to reduce cardiovascular risk.

In this clinical audit you will conduct a review of patients with pancreatic exocrine insufficiency (PEI) who are currently receiving PERT (pancreatic enzyme replacement therapy), in order to assess their quality of life and treatment effectiveness, and optimise their therapy.

In this two-part clinical audit, you will review your past management of patients with type 2 diabetes and overweight or obesity, then utilise your learnings to guide effective glycaemic and weight management of further patients.

Review your management of patients with HFrEF (heart failure with reduced ejection fraction) in this clinical audit, and update their treatment to be in line with latest recommendations including the "four pillars" approach.

Develop a practical understanding of the evolving role of oral antiviral therapy in the management of COVID-19 in this brand new education activity, with an opportunity to review your knowledge through a series of case studies.